In vitro activities of contezolid (MRX-I) against drug-sensitive and drug-resistant Mycobacterium tuberculosis

A novel oxazolidinone for the treatment of Mycobacterium tuberculosis has been developed, but the activity of contezolid (MRX-I) still needs to be clarified. In this study, we isolated Mycobacterium tuberculosis from 48 clinical patients with pulmonary tuberculosis. Roche drug susceptibility tests i...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Huiru, Sun, Wenna, Liu, Xiao, Wang, Tianhao, Qiao, Juan, Liang, Jianqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580816/
https://www.ncbi.nlm.nih.gov/pubmed/37732805
http://dx.doi.org/10.1128/spectrum.04627-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580816/
https://www.ncbi.nlm.nih.gov/pubmed/37732805
http://dx.doi.org/10.1128/spectrum.04627-22

Ejemplares similares